nodes	percent_of_prediction	percent_of_DWPC	metapath
Rizatriptan—Angiopathy—Vincristine—muscle cancer	0.00482	0.00482	CcSEcCtD
Rizatriptan—Acute coronary syndrome—Etoposide—muscle cancer	0.00472	0.00472	CcSEcCtD
Rizatriptan—Dysarthria—Doxorubicin—muscle cancer	0.00469	0.00469	CcSEcCtD
Rizatriptan—Myocardial infarction—Etoposide—muscle cancer	0.00469	0.00469	CcSEcCtD
Rizatriptan—Mental disorder—Vincristine—muscle cancer	0.00465	0.00465	CcSEcCtD
Rizatriptan—Urine output increased—Methotrexate—muscle cancer	0.00464	0.00464	CcSEcCtD
Rizatriptan—Gait disturbance—Doxorubicin—muscle cancer	0.00455	0.00455	CcSEcCtD
Rizatriptan—Coordination abnormal—Doxorubicin—muscle cancer	0.00452	0.00452	CcSEcCtD
Rizatriptan—Neck pain—Doxorubicin—muscle cancer	0.00449	0.00449	CcSEcCtD
Rizatriptan—Musculoskeletal pain—Doxorubicin—muscle cancer	0.00449	0.00449	CcSEcCtD
Rizatriptan—Ventricular tachycardia—Doxorubicin—muscle cancer	0.00444	0.00444	CcSEcCtD
Rizatriptan—Hiccups—Doxorubicin—muscle cancer	0.00444	0.00444	CcSEcCtD
Rizatriptan—Myalgia—Dactinomycin—muscle cancer	0.0044	0.0044	CcSEcCtD
Rizatriptan—Eructation—Doxorubicin—muscle cancer	0.00436	0.00436	CcSEcCtD
Rizatriptan—Discomfort—Dactinomycin—muscle cancer	0.00435	0.00435	CcSEcCtD
Rizatriptan—Hypoaesthesia—Etoposide—muscle cancer	0.00428	0.00428	CcSEcCtD
Rizatriptan—Agitation—Vincristine—muscle cancer	0.00425	0.00425	CcSEcCtD
Rizatriptan—Photosensitivity—Methotrexate—muscle cancer	0.00424	0.00424	CcSEcCtD
Rizatriptan—Polyuria—Methotrexate—muscle cancer	0.00424	0.00424	CcSEcCtD
Rizatriptan—Oedema—Dactinomycin—muscle cancer	0.00422	0.00422	CcSEcCtD
Rizatriptan—Vertigo—Vincristine—muscle cancer	0.00415	0.00415	CcSEcCtD
Rizatriptan—Dry eye—Doxorubicin—muscle cancer	0.0041	0.0041	CcSEcCtD
Rizatriptan—Anorexia—Dactinomycin—muscle cancer	0.00402	0.00402	CcSEcCtD
Rizatriptan—Convulsion—Vincristine—muscle cancer	0.004	0.004	CcSEcCtD
Rizatriptan—Flushing—Etoposide—muscle cancer	0.00399	0.00399	CcSEcCtD
Rizatriptan—Hypertension—Vincristine—muscle cancer	0.00399	0.00399	CcSEcCtD
Rizatriptan—Myalgia—Vincristine—muscle cancer	0.00393	0.00393	CcSEcCtD
Rizatriptan—Angiopathy—Etoposide—muscle cancer	0.0039	0.0039	CcSEcCtD
Rizatriptan—Chills—Etoposide—muscle cancer	0.00386	0.00386	CcSEcCtD
Rizatriptan—Anaphylactoid reaction—Methotrexate—muscle cancer	0.00385	0.00385	CcSEcCtD
Rizatriptan—Musculoskeletal discomfort—Dactinomycin—muscle cancer	0.00385	0.00385	CcSEcCtD
Rizatriptan—Cerebrovascular accident—Methotrexate—muscle cancer	0.0038	0.0038	CcSEcCtD
Rizatriptan—Oedema—Vincristine—muscle cancer	0.00377	0.00377	CcSEcCtD
Rizatriptan—Anaphylactic shock—Vincristine—muscle cancer	0.00377	0.00377	CcSEcCtD
Rizatriptan—Osteoarthritis—Methotrexate—muscle cancer	0.00372	0.00372	CcSEcCtD
Rizatriptan—Nervous system disorder—Vincristine—muscle cancer	0.0037	0.0037	CcSEcCtD
Rizatriptan—Photosensitivity—Doxorubicin—muscle cancer	0.00367	0.00367	CcSEcCtD
Rizatriptan—Decreased appetite—Dactinomycin—muscle cancer	0.00367	0.00367	CcSEcCtD
Rizatriptan—Dysgeusia—Etoposide—muscle cancer	0.00367	0.00367	CcSEcCtD
Rizatriptan—Hyperhidrosis—Vincristine—muscle cancer	0.00365	0.00365	CcSEcCtD
Rizatriptan—Fatigue—Dactinomycin—muscle cancer	0.00364	0.00364	CcSEcCtD
Rizatriptan—Pain—Dactinomycin—muscle cancer	0.00361	0.00361	CcSEcCtD
Rizatriptan—Muscle spasms—Etoposide—muscle cancer	0.0036	0.0036	CcSEcCtD
Rizatriptan—Anorexia—Vincristine—muscle cancer	0.00359	0.00359	CcSEcCtD
Rizatriptan—Eye pain—Doxorubicin—muscle cancer	0.00357	0.00357	CcSEcCtD
Rizatriptan—Irritability—Methotrexate—muscle cancer	0.00355	0.00355	CcSEcCtD
Rizatriptan—Ataxia—Methotrexate—muscle cancer	0.0035	0.0035	CcSEcCtD
Rizatriptan—Feeling abnormal—Dactinomycin—muscle cancer	0.00348	0.00348	CcSEcCtD
Rizatriptan—Gastrointestinal pain—Dactinomycin—muscle cancer	0.00345	0.00345	CcSEcCtD
Rizatriptan—Hot flush—Doxorubicin—muscle cancer	0.00345	0.00345	CcSEcCtD
Rizatriptan—Musculoskeletal discomfort—Vincristine—muscle cancer	0.00344	0.00344	CcSEcCtD
Rizatriptan—Increased appetite—Doxorubicin—muscle cancer	0.00343	0.00343	CcSEcCtD
Rizatriptan—Menopausal symptoms—Doxorubicin—muscle cancer	0.00342	0.00342	CcSEcCtD
Rizatriptan—Insomnia—Vincristine—muscle cancer	0.00341	0.00341	CcSEcCtD
Rizatriptan—Paraesthesia—Vincristine—muscle cancer	0.00339	0.00339	CcSEcCtD
Rizatriptan—Vertigo—Etoposide—muscle cancer	0.00336	0.00336	CcSEcCtD
Rizatriptan—Toxic epidermal necrolysis—Methotrexate—muscle cancer	0.00335	0.00335	CcSEcCtD
Rizatriptan—Body temperature increased—Dactinomycin—muscle cancer	0.00334	0.00334	CcSEcCtD
Rizatriptan—Abdominal pain—Dactinomycin—muscle cancer	0.00334	0.00334	CcSEcCtD
Rizatriptan—Anaphylactoid reaction—Doxorubicin—muscle cancer	0.00333	0.00333	CcSEcCtD
Rizatriptan—Loss of consciousness—Etoposide—muscle cancer	0.00329	0.00329	CcSEcCtD
Rizatriptan—Cerebrovascular accident—Doxorubicin—muscle cancer	0.00329	0.00329	CcSEcCtD
Rizatriptan—Decreased appetite—Vincristine—muscle cancer	0.00328	0.00328	CcSEcCtD
Rizatriptan—Cough—Etoposide—muscle cancer	0.00327	0.00327	CcSEcCtD
Rizatriptan—Gastrointestinal disorder—Vincristine—muscle cancer	0.00326	0.00326	CcSEcCtD
Rizatriptan—Fatigue—Vincristine—muscle cancer	0.00325	0.00325	CcSEcCtD
Rizatriptan—Convulsion—Etoposide—muscle cancer	0.00324	0.00324	CcSEcCtD
Rizatriptan—Hypertension—Etoposide—muscle cancer	0.00323	0.00323	CcSEcCtD
Rizatriptan—Pain—Vincristine—muscle cancer	0.00322	0.00322	CcSEcCtD
Rizatriptan—Constipation—Vincristine—muscle cancer	0.00322	0.00322	CcSEcCtD
Rizatriptan—Osteoarthritis—Doxorubicin—muscle cancer	0.00322	0.00322	CcSEcCtD
Rizatriptan—Chest pain—Etoposide—muscle cancer	0.00319	0.00319	CcSEcCtD
Rizatriptan—Discomfort—Etoposide—muscle cancer	0.00315	0.00315	CcSEcCtD
Rizatriptan—Face oedema—Doxorubicin—muscle cancer	0.00311	0.00311	CcSEcCtD
Rizatriptan—Hypersensitivity—Dactinomycin—muscle cancer	0.00311	0.00311	CcSEcCtD
Rizatriptan—Abdominal discomfort—Methotrexate—muscle cancer	0.00308	0.00308	CcSEcCtD
Rizatriptan—Gastrointestinal pain—Vincristine—muscle cancer	0.00308	0.00308	CcSEcCtD
Rizatriptan—Confusional state—Etoposide—muscle cancer	0.00308	0.00308	CcSEcCtD
Rizatriptan—Anaphylactic shock—Etoposide—muscle cancer	0.00305	0.00305	CcSEcCtD
Rizatriptan—Ataxia—Doxorubicin—muscle cancer	0.00303	0.00303	CcSEcCtD
Rizatriptan—Asthenia—Dactinomycin—muscle cancer	0.00303	0.00303	CcSEcCtD
Rizatriptan—Dysuria—Methotrexate—muscle cancer	0.00301	0.00301	CcSEcCtD
Rizatriptan—Dehydration—Doxorubicin—muscle cancer	0.003	0.003	CcSEcCtD
Rizatriptan—Upper respiratory tract infection—Methotrexate—muscle cancer	0.00299	0.00299	CcSEcCtD
Rizatriptan—Tachycardia—Etoposide—muscle cancer	0.00298	0.00298	CcSEcCtD
Rizatriptan—Abdominal pain—Vincristine—muscle cancer	0.00298	0.00298	CcSEcCtD
Rizatriptan—Body temperature increased—Vincristine—muscle cancer	0.00298	0.00298	CcSEcCtD
Rizatriptan—Hyperhidrosis—Etoposide—muscle cancer	0.00295	0.00295	CcSEcCtD
Rizatriptan—Photosensitivity reaction—Methotrexate—muscle cancer	0.00294	0.00294	CcSEcCtD
Rizatriptan—Anorexia—Etoposide—muscle cancer	0.00291	0.00291	CcSEcCtD
Rizatriptan—Toxic epidermal necrolysis—Doxorubicin—muscle cancer	0.0029	0.0029	CcSEcCtD
Rizatriptan—Diarrhoea—Dactinomycin—muscle cancer	0.00289	0.00289	CcSEcCtD
Rizatriptan—Nasopharyngitis—Doxorubicin—muscle cancer	0.00288	0.00288	CcSEcCtD
Rizatriptan—Gastritis—Doxorubicin—muscle cancer	0.00285	0.00285	CcSEcCtD
Rizatriptan—Muscular weakness—Doxorubicin—muscle cancer	0.00284	0.00284	CcSEcCtD
Rizatriptan—Abdominal distension—Doxorubicin—muscle cancer	0.0028	0.0028	CcSEcCtD
Rizatriptan—Dysphagia—Doxorubicin—muscle cancer	0.00279	0.00279	CcSEcCtD
Rizatriptan—Hypersensitivity—Vincristine—muscle cancer	0.00278	0.00278	CcSEcCtD
Rizatriptan—Sweating—Methotrexate—muscle cancer	0.00275	0.00275	CcSEcCtD
Rizatriptan—Paraesthesia—Etoposide—muscle cancer	0.00274	0.00274	CcSEcCtD
Rizatriptan—Dyspnoea—Etoposide—muscle cancer	0.00272	0.00272	CcSEcCtD
Rizatriptan—Somnolence—Etoposide—muscle cancer	0.00272	0.00272	CcSEcCtD
Rizatriptan—Angina pectoris—Doxorubicin—muscle cancer	0.00271	0.00271	CcSEcCtD
Rizatriptan—Epistaxis—Methotrexate—muscle cancer	0.00271	0.00271	CcSEcCtD
Rizatriptan—Asthenia—Vincristine—muscle cancer	0.00271	0.00271	CcSEcCtD
Rizatriptan—Vomiting—Dactinomycin—muscle cancer	0.00268	0.00268	CcSEcCtD
Rizatriptan—Rash—Dactinomycin—muscle cancer	0.00266	0.00266	CcSEcCtD
Rizatriptan—Decreased appetite—Etoposide—muscle cancer	0.00266	0.00266	CcSEcCtD
Rizatriptan—Gastrointestinal disorder—Etoposide—muscle cancer	0.00264	0.00264	CcSEcCtD
Rizatriptan—Fatigue—Etoposide—muscle cancer	0.00263	0.00263	CcSEcCtD
Rizatriptan—Pain—Etoposide—muscle cancer	0.00261	0.00261	CcSEcCtD
Rizatriptan—Constipation—Etoposide—muscle cancer	0.00261	0.00261	CcSEcCtD
Rizatriptan—Dysuria—Doxorubicin—muscle cancer	0.00261	0.00261	CcSEcCtD
Rizatriptan—Upper respiratory tract infection—Doxorubicin—muscle cancer	0.00259	0.00259	CcSEcCtD
Rizatriptan—Diarrhoea—Vincristine—muscle cancer	0.00258	0.00258	CcSEcCtD
Rizatriptan—Pollakiuria—Doxorubicin—muscle cancer	0.00257	0.00257	CcSEcCtD
Rizatriptan—Pharyngitis—Methotrexate—muscle cancer	0.00256	0.00256	CcSEcCtD
Rizatriptan—Photosensitivity reaction—Doxorubicin—muscle cancer	0.00254	0.00254	CcSEcCtD
Rizatriptan—Feeling abnormal—Etoposide—muscle cancer	0.00252	0.00252	CcSEcCtD
Rizatriptan—Nausea—Dactinomycin—muscle cancer	0.00251	0.00251	CcSEcCtD
Rizatriptan—Gastrointestinal pain—Etoposide—muscle cancer	0.0025	0.0025	CcSEcCtD
Rizatriptan—Dizziness—Vincristine—muscle cancer	0.00249	0.00249	CcSEcCtD
Rizatriptan—Urticaria—Etoposide—muscle cancer	0.00243	0.00243	CcSEcCtD
Rizatriptan—Abdominal pain—Etoposide—muscle cancer	0.00241	0.00241	CcSEcCtD
Rizatriptan—Body temperature increased—Etoposide—muscle cancer	0.00241	0.00241	CcSEcCtD
Rizatriptan—Tinnitus—Methotrexate—muscle cancer	0.0024	0.0024	CcSEcCtD
Rizatriptan—Vomiting—Vincristine—muscle cancer	0.0024	0.0024	CcSEcCtD
Rizatriptan—Sweating—Doxorubicin—muscle cancer	0.00238	0.00238	CcSEcCtD
Rizatriptan—Rash—Vincristine—muscle cancer	0.00238	0.00238	CcSEcCtD
Rizatriptan—Dermatitis—Vincristine—muscle cancer	0.00238	0.00238	CcSEcCtD
Rizatriptan—Headache—Vincristine—muscle cancer	0.00236	0.00236	CcSEcCtD
Rizatriptan—Epistaxis—Doxorubicin—muscle cancer	0.00234	0.00234	CcSEcCtD
Rizatriptan—Angiopathy—Methotrexate—muscle cancer	0.00234	0.00234	CcSEcCtD
Rizatriptan—Chills—Methotrexate—muscle cancer	0.00231	0.00231	CcSEcCtD
Rizatriptan—Bradycardia—Doxorubicin—muscle cancer	0.00227	0.00227	CcSEcCtD
Rizatriptan—Mental disorder—Methotrexate—muscle cancer	0.00226	0.00226	CcSEcCtD
Rizatriptan—Hypersensitivity—Etoposide—muscle cancer	0.00225	0.00225	CcSEcCtD
Rizatriptan—Erythema—Methotrexate—muscle cancer	0.00224	0.00224	CcSEcCtD
Rizatriptan—Nausea—Vincristine—muscle cancer	0.00224	0.00224	CcSEcCtD
Rizatriptan—Hypoaesthesia—Doxorubicin—muscle cancer	0.00222	0.00222	CcSEcCtD
Rizatriptan—Pharyngitis—Doxorubicin—muscle cancer	0.00221	0.00221	CcSEcCtD
Rizatriptan—Dysgeusia—Methotrexate—muscle cancer	0.0022	0.0022	CcSEcCtD
Rizatriptan—Asthenia—Etoposide—muscle cancer	0.00219	0.00219	CcSEcCtD
Rizatriptan—Pruritus—Etoposide—muscle cancer	0.00216	0.00216	CcSEcCtD
Rizatriptan—Vision blurred—Methotrexate—muscle cancer	0.00211	0.00211	CcSEcCtD
Rizatriptan—Diarrhoea—Etoposide—muscle cancer	0.00209	0.00209	CcSEcCtD
Rizatriptan—Tinnitus—Doxorubicin—muscle cancer	0.00208	0.00208	CcSEcCtD
Rizatriptan—Flushing—Doxorubicin—muscle cancer	0.00207	0.00207	CcSEcCtD
Rizatriptan—Angiopathy—Doxorubicin—muscle cancer	0.00202	0.00202	CcSEcCtD
Rizatriptan—Dizziness—Etoposide—muscle cancer	0.00202	0.00202	CcSEcCtD
Rizatriptan—Vertigo—Methotrexate—muscle cancer	0.00201	0.00201	CcSEcCtD
Rizatriptan—Chills—Doxorubicin—muscle cancer	0.002	0.002	CcSEcCtD
Rizatriptan—Arrhythmia—Doxorubicin—muscle cancer	0.00199	0.00199	CcSEcCtD
Rizatriptan—Cough—Methotrexate—muscle cancer	0.00196	0.00196	CcSEcCtD
Rizatriptan—Mental disorder—Doxorubicin—muscle cancer	0.00195	0.00195	CcSEcCtD
Rizatriptan—Convulsion—Methotrexate—muscle cancer	0.00194	0.00194	CcSEcCtD
Rizatriptan—Vomiting—Etoposide—muscle cancer	0.00194	0.00194	CcSEcCtD
Rizatriptan—Erythema—Doxorubicin—muscle cancer	0.00194	0.00194	CcSEcCtD
Rizatriptan—Rash—Etoposide—muscle cancer	0.00193	0.00193	CcSEcCtD
Rizatriptan—Dermatitis—Etoposide—muscle cancer	0.00192	0.00192	CcSEcCtD
Rizatriptan—Headache—Etoposide—muscle cancer	0.00191	0.00191	CcSEcCtD
Rizatriptan—Flatulence—Doxorubicin—muscle cancer	0.00191	0.00191	CcSEcCtD
Rizatriptan—Arthralgia—Methotrexate—muscle cancer	0.00191	0.00191	CcSEcCtD
Rizatriptan—Myalgia—Methotrexate—muscle cancer	0.00191	0.00191	CcSEcCtD
Rizatriptan—Chest pain—Methotrexate—muscle cancer	0.00191	0.00191	CcSEcCtD
Rizatriptan—Tension—Doxorubicin—muscle cancer	0.0019	0.0019	CcSEcCtD
Rizatriptan—Dysgeusia—Doxorubicin—muscle cancer	0.0019	0.0019	CcSEcCtD
Rizatriptan—Discomfort—Methotrexate—muscle cancer	0.00189	0.00189	CcSEcCtD
Rizatriptan—Nervousness—Doxorubicin—muscle cancer	0.00189	0.00189	CcSEcCtD
Rizatriptan—Muscle spasms—Doxorubicin—muscle cancer	0.00187	0.00187	CcSEcCtD
Rizatriptan—Confusional state—Methotrexate—muscle cancer	0.00184	0.00184	CcSEcCtD
Rizatriptan—Anaphylactic shock—Methotrexate—muscle cancer	0.00183	0.00183	CcSEcCtD
Rizatriptan—Vision blurred—Doxorubicin—muscle cancer	0.00183	0.00183	CcSEcCtD
Rizatriptan—Nausea—Etoposide—muscle cancer	0.00181	0.00181	CcSEcCtD
Rizatriptan—Nervous system disorder—Methotrexate—muscle cancer	0.00179	0.00179	CcSEcCtD
Rizatriptan—Agitation—Doxorubicin—muscle cancer	0.00178	0.00178	CcSEcCtD
Rizatriptan—Hyperhidrosis—Methotrexate—muscle cancer	0.00177	0.00177	CcSEcCtD
Rizatriptan—Vertigo—Doxorubicin—muscle cancer	0.00174	0.00174	CcSEcCtD
Rizatriptan—Anorexia—Methotrexate—muscle cancer	0.00174	0.00174	CcSEcCtD
Rizatriptan—Syncope—Doxorubicin—muscle cancer	0.00174	0.00174	CcSEcCtD
Rizatriptan—Palpitations—Doxorubicin—muscle cancer	0.00172	0.00172	CcSEcCtD
Rizatriptan—Loss of consciousness—Doxorubicin—muscle cancer	0.00171	0.00171	CcSEcCtD
Rizatriptan—Cough—Doxorubicin—muscle cancer	0.00169	0.00169	CcSEcCtD
Rizatriptan—Convulsion—Doxorubicin—muscle cancer	0.00168	0.00168	CcSEcCtD
Rizatriptan—Hypertension—Doxorubicin—muscle cancer	0.00168	0.00168	CcSEcCtD
Rizatriptan—Musculoskeletal discomfort—Methotrexate—muscle cancer	0.00167	0.00167	CcSEcCtD
Rizatriptan—Insomnia—Methotrexate—muscle cancer	0.00165	0.00165	CcSEcCtD
Rizatriptan—Chest pain—Doxorubicin—muscle cancer	0.00165	0.00165	CcSEcCtD
Rizatriptan—Myalgia—Doxorubicin—muscle cancer	0.00165	0.00165	CcSEcCtD
Rizatriptan—Arthralgia—Doxorubicin—muscle cancer	0.00165	0.00165	CcSEcCtD
Rizatriptan—Anxiety—Doxorubicin—muscle cancer	0.00165	0.00165	CcSEcCtD
Rizatriptan—Paraesthesia—Methotrexate—muscle cancer	0.00164	0.00164	CcSEcCtD
Rizatriptan—Discomfort—Doxorubicin—muscle cancer	0.00163	0.00163	CcSEcCtD
Rizatriptan—Dyspnoea—Methotrexate—muscle cancer	0.00163	0.00163	CcSEcCtD
Rizatriptan—Somnolence—Methotrexate—muscle cancer	0.00163	0.00163	CcSEcCtD
Rizatriptan—Dry mouth—Doxorubicin—muscle cancer	0.00162	0.00162	CcSEcCtD
Rizatriptan—Dyspepsia—Methotrexate—muscle cancer	0.00161	0.00161	CcSEcCtD
Rizatriptan—Confusional state—Doxorubicin—muscle cancer	0.0016	0.0016	CcSEcCtD
Rizatriptan—Decreased appetite—Methotrexate—muscle cancer	0.00159	0.00159	CcSEcCtD
Rizatriptan—Oedema—Doxorubicin—muscle cancer	0.00158	0.00158	CcSEcCtD
Rizatriptan—Anaphylactic shock—Doxorubicin—muscle cancer	0.00158	0.00158	CcSEcCtD
Rizatriptan—Gastrointestinal disorder—Methotrexate—muscle cancer	0.00158	0.00158	CcSEcCtD
Rizatriptan—Fatigue—Methotrexate—muscle cancer	0.00158	0.00158	CcSEcCtD
Rizatriptan—Pain—Methotrexate—muscle cancer	0.00156	0.00156	CcSEcCtD
Rizatriptan—Shock—Doxorubicin—muscle cancer	0.00156	0.00156	CcSEcCtD
Rizatriptan—Nervous system disorder—Doxorubicin—muscle cancer	0.00155	0.00155	CcSEcCtD
Rizatriptan—Tachycardia—Doxorubicin—muscle cancer	0.00155	0.00155	CcSEcCtD
Rizatriptan—Hyperhidrosis—Doxorubicin—muscle cancer	0.00153	0.00153	CcSEcCtD
Rizatriptan—Anorexia—Doxorubicin—muscle cancer	0.00151	0.00151	CcSEcCtD
Rizatriptan—Feeling abnormal—Methotrexate—muscle cancer	0.00151	0.00151	CcSEcCtD
Rizatriptan—Gastrointestinal pain—Methotrexate—muscle cancer	0.0015	0.0015	CcSEcCtD
Rizatriptan—Urticaria—Methotrexate—muscle cancer	0.00145	0.00145	CcSEcCtD
Rizatriptan—Body temperature increased—Methotrexate—muscle cancer	0.00145	0.00145	CcSEcCtD
Rizatriptan—Abdominal pain—Methotrexate—muscle cancer	0.00145	0.00145	CcSEcCtD
Rizatriptan—Musculoskeletal discomfort—Doxorubicin—muscle cancer	0.00144	0.00144	CcSEcCtD
Rizatriptan—Insomnia—Doxorubicin—muscle cancer	0.00143	0.00143	CcSEcCtD
Rizatriptan—Paraesthesia—Doxorubicin—muscle cancer	0.00142	0.00142	CcSEcCtD
Rizatriptan—Dyspnoea—Doxorubicin—muscle cancer	0.00141	0.00141	CcSEcCtD
Rizatriptan—Somnolence—Doxorubicin—muscle cancer	0.00141	0.00141	CcSEcCtD
Rizatriptan—Dyspepsia—Doxorubicin—muscle cancer	0.00139	0.00139	CcSEcCtD
Rizatriptan—Decreased appetite—Doxorubicin—muscle cancer	0.00138	0.00138	CcSEcCtD
Rizatriptan—Gastrointestinal disorder—Doxorubicin—muscle cancer	0.00137	0.00137	CcSEcCtD
Rizatriptan—Fatigue—Doxorubicin—muscle cancer	0.00137	0.00137	CcSEcCtD
Rizatriptan—Constipation—Doxorubicin—muscle cancer	0.00135	0.00135	CcSEcCtD
Rizatriptan—Pain—Doxorubicin—muscle cancer	0.00135	0.00135	CcSEcCtD
Rizatriptan—Hypersensitivity—Methotrexate—muscle cancer	0.00135	0.00135	CcSEcCtD
Rizatriptan—Asthenia—Methotrexate—muscle cancer	0.00131	0.00131	CcSEcCtD
Rizatriptan—Feeling abnormal—Doxorubicin—muscle cancer	0.00131	0.00131	CcSEcCtD
Rizatriptan—Gastrointestinal pain—Doxorubicin—muscle cancer	0.0013	0.0013	CcSEcCtD
Rizatriptan—Pruritus—Methotrexate—muscle cancer	0.00129	0.00129	CcSEcCtD
Rizatriptan—Urticaria—Doxorubicin—muscle cancer	0.00126	0.00126	CcSEcCtD
Rizatriptan—Abdominal pain—Doxorubicin—muscle cancer	0.00125	0.00125	CcSEcCtD
Rizatriptan—Body temperature increased—Doxorubicin—muscle cancer	0.00125	0.00125	CcSEcCtD
Rizatriptan—Diarrhoea—Methotrexate—muscle cancer	0.00125	0.00125	CcSEcCtD
Rizatriptan—Dizziness—Methotrexate—muscle cancer	0.00121	0.00121	CcSEcCtD
Rizatriptan—Hypersensitivity—Doxorubicin—muscle cancer	0.00117	0.00117	CcSEcCtD
Rizatriptan—Vomiting—Methotrexate—muscle cancer	0.00116	0.00116	CcSEcCtD
Rizatriptan—Rash—Methotrexate—muscle cancer	0.00115	0.00115	CcSEcCtD
Rizatriptan—Dermatitis—Methotrexate—muscle cancer	0.00115	0.00115	CcSEcCtD
Rizatriptan—Headache—Methotrexate—muscle cancer	0.00115	0.00115	CcSEcCtD
Rizatriptan—Asthenia—Doxorubicin—muscle cancer	0.00114	0.00114	CcSEcCtD
Rizatriptan—Pruritus—Doxorubicin—muscle cancer	0.00112	0.00112	CcSEcCtD
Rizatriptan—Nausea—Methotrexate—muscle cancer	0.00109	0.00109	CcSEcCtD
Rizatriptan—Diarrhoea—Doxorubicin—muscle cancer	0.00108	0.00108	CcSEcCtD
Rizatriptan—Dizziness—Doxorubicin—muscle cancer	0.00105	0.00105	CcSEcCtD
Rizatriptan—Vomiting—Doxorubicin—muscle cancer	0.00101	0.00101	CcSEcCtD
Rizatriptan—Rash—Doxorubicin—muscle cancer	0.000999	0.000999	CcSEcCtD
Rizatriptan—Dermatitis—Doxorubicin—muscle cancer	0.000998	0.000998	CcSEcCtD
Rizatriptan—Headache—Doxorubicin—muscle cancer	0.000993	0.000993	CcSEcCtD
Rizatriptan—Nausea—Doxorubicin—muscle cancer	0.000941	0.000941	CcSEcCtD
